Catumaxomab (LP-000) is a rat-mouse hybrid lgG2 monoclonal and bispecific antibody that binds to the antigens CD3 and EpCAM (Epithelial Cell Adhesion Molecule) for the treatment of malignant ascites in cancer patients.
Purity:
95.00%
CAS Number:
[509077-98-9]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted